Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial

BACKGROUND: The FMP2.1/AS02(A) candidate malaria vaccine was tested in a Phase 2 study in Mali. Based on results from the first eight months of follow-up, the vaccine appeared well-tolerated and immunogenic. It had no significant efficacy based on the primary endpoint, clinical malaria, but marginal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Laurens, Matthew B., Thera, Mahamadou A., Coulibaly, Drissa, Ouattara, Amed, Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Traore, Idrissa, Kouriba, Bourema, Diallo, Dapa A., Diarra, Issa, Daou, Modibo, Dolo, Amagana, Tolo, Youssouf, Sissoko, Mahamadou S., Niangaly, Amadou, Sissoko, Mady, Takala-Harrison, Shannon, Lyke, Kirsten E., Wu, Yukun, Blackwelder, William C., Godeaux, Olivier, Vekemans, Johan, Dubois, Marie-Claude, Ballou, W. Ripley, Cohen, Joe, Dube, Tina, Soisson, Lorraine, Diggs, Carter L., House, Brent, Bennett, Jason W., Lanar, David E., Dutta, Sheetij, Heppner, D. Gray, Plowe, Christopher V., Doumbo, Ogobara K.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832522/
https://ncbi.nlm.nih.gov/pubmed/24260195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados